Modeling mortality risk in hemodialysis patients using laboratory values as time-dependent covariates

American Journal of Kidney Diseases

Volumn 28, Issue 5, 1996, Pages 741-746

  Culp, Kennith ^a   Flanigan, Michael ^b   Lowrie, Edmund G ^b   Lew, Nancy ^b   Zimmerman, Bridget ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

albumin; creatinine; hematocrit; hemodialysis; Mortality risk; time dependent

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HEMATOCRIT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; RISK;

EID: 0029911965     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-6386(96)90258-9     Document Type: Article

References (31)

1. United States Renal Data System: USRDS Core Indicators Project. Baltimore, MD, HCFA, HSQB, DHHS, 1996
2. Nissen A, Port F: Outcome of end-stage renal disease in patients with rare causes of renal failure: Systemic/vascular disorders. Q J Med 273:63-74, 1990
3. Schiller G, Berkman A: Hematologic aspects of renal insufficiency. Blood Rev 3:141-146, 1989
4. Latham D, Geisman J: Case management of the anemic patient. Am Nephrol Nurses Assoc J 18:588-589, 1991
5. Anonymous: Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38, 1992 (suppl 2)
6. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23:808-816, 1994
7. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 14:121-126, 1994
8. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R: Death risk in CAPD patients: The predictive value of the initial clinical and laboratory variables. Nephron 65:23-27, 1993
9. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 22:215-225, 1993
10. Cox DR: Regression models and life tables. J Rev Stat Soc Behav 34:187-220, 1972
11. Freedman LS: Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1:121-129, 1982
12. Kaplan EL, Meyer P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Altaian DG, De Stavola BL: Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 13:301-341, 1994
14. Hess KR: Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions. Stat Med 13:1045-1062, 1994
15. Santiago GC, Sreepada TK, Laird NM: Effect of dialysis therapy on the hematopoietic system: The National Cooperative Dialysis Study. Kidney Int 23:S95-S100, 1983 (suppl 13)
16. Charra B: Control of blood pressure in long slow hemodialysis. Blood Purif 12:252-258, 1994
17. Parfrey PS, Harnett JD: Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif 12:267-276, 1994
18. Capelli JP, Kushner H, Camiscioli T, Chen SM, Stuccio-White NM: Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times. Am J Nephrol 12:212-223, 1992
19. Parfrey PS, Harnett JD: Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology. ASAIO J 40:121-129, 1994
20. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19:214-234, 1992
21. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3:1613-1622, 1993
22. Parfrey PS, Harnett JD: Clinical aspects of cardiomyopathy in dialysis patients. Blood Purif 12:267-276, 1994
23. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 22:215-225, 1993
24. Lowrie EG, Lew NL, Liu Y: The relative contribution of measured variables to death risk among hemodialysis patients, in Friedman EA (ed): Death on Hemodialysis. the Netherlands, Kluwer Academic, 1992, pp 121-141
25. Bleiler RE, Schedll HP: Creatinine excretion: Variability and relationships to diet and body size. J Lab Clin Med 59:945-955, 1962
26. Heysmith SB, Arteaga C, McManus C: Measurement of muscle mass in humans: Validity of the 24 hour urinary creatinine method. Am J Clin Nutr 37:478-494, 1983
27. Lowie EG, Lew NL: Commonly measured laboratory variables in hemodialysis patients: Relationships among them to death risk. Semin Nephrol 12:276-283, 1992
28. Lowrie E, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
29. Lowrie EG, Huang WH, Lew NL: Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison. Am J Kidney Dis 26:220-228, 1995
30. Parker TF III, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23:670-680, 1994
31. Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24:912-920, 1994